Contract HHSN27500007
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · Department Of Health And Human Services · September 9, 2021
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 9, 2021 for $299,000 of work in research and development in biotechnology. Performance is in Torrance, CA. This is a task or delivery order issued under parent IDIQ HHSN275201300024I. The contract has been modified 3 times since the base award It uses cost no fee contract pricing. The most recent modification was on December 15, 2025. If all options are exercised, the contract could reach $11.79 million.
Contract details
- PIID
- HHSN27500007
- Parent IDIQ
- HHSN275201300024I
- Award type
- Delivery Order
- Pricing
- Cost No Fee
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Torrance, CA
- First action
- September 9, 2021
- Latest action
- December 15, 2025
Description
NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE
Modification timeline
-
December 15, 2025Mod P00008 · Other Administrative Action$11.79M
-
September 25, 2024Mod P00007 · Supplemental Agreement For Work Within ScopeCONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL CONTRACT HHSN275201300024I HHSN27500007$11.79M
-
September 18, 2024Mod P00006 · Other Administrative ActionCONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL CONTRACT HHSN275201300024I HHSN27500007$11.49M
-
September 9, 2021Mod P00004 · Other Administrative ActionCLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION - CENTRAL LABORATORY$160.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN27500007?
Contract HHSN27500007 is a federal contract awarded to Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center by Department Of Health And Human Services on September 9, 2021 for $299,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 3 times since the base award.
Who won contract HHSN27500007?
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center won contract HHSN27500007 from Department Of Health And Human Services.
How much is contract HHSN27500007 worth?
Contract HHSN27500007 has obligated $299,000 to date, with a total potential value of $11.79 million if all options are exercised.